Satellos Bioscience (MSLE) Earnings Analysis
Satellos Bioscience (MSLE) next reports earnings on 2026-08-12, consensus EPS -0.51075 USD. Last quarter (2026-05-14) it missed with EPS -0.53 USD vs -0.51 USD est (-3.9%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -1.75.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MSLE next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.51075 USD |
| Revenue estimate | n/a |
MSLE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.53 USD | -0.51 USD | -3.9% | Miss |
| 2026-03-27 | -0.47 USD | -0.36 USD | -30.6% | Miss |
| 2025-11-14 | -0.36261 USD | -0.32625 USD | -11.1% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
MSLE valuation and analyst view
| Trailing P/E | -1.75 |
|---|---|
| Trailing EPS | -0.31733 USD |
| Price / book | 0.49 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
| Avg price target | 19.67 USD |
Related research pages
Frequently asked questions
When is Satellos Bioscience (MSLE)'s next earnings date?
Satellos Bioscience is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.51075 USD.
Did MSLE beat earnings last quarter?
In its 2026-05-14 report, MSLE posted EPS of -0.53 USD versus a -0.51 USD estimate — a miss of 3.9%.
What is MSLE's earnings track record?
Over the last 3 reported quarters with consensus data, MSLE beat estimates 0 times (0%).
What is MSLE's current P/E ratio and EPS?
MSLE trades at a trailing P/E of -1.75 on trailing EPS of -0.31733187055769696 USD.
What do analysts rate MSLE?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 19.67 USD.